Miscellaneous News

CAR T-Cell Therapy for Cancer

March 20 , 2025 14 hrs 0 min 68 0

The clinical trial results of India’s first CAR T-cell therapy worked for nearly 73 per cent of patients.
This is the first clinical trial of a CAR T-cell therapy from India to be published in an international journal.
CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, trains the body’s own immune cells to identify and destroy cancer cells.
This treatment is designed for the specific types of blood cancer and is given to patients whose cancer has either relapsed or not responded to first-line treatment.
For any CAR T-cell therapy, a patient’s immune T-cells are collected by filtering their blood.
These cells are then engineered in a lab to add receptors that can bind with the cancer cells.
These cells are then multiplied and infused in the patient.